Publication:
A novel EFNB1 mutation in a patient with craniofrontonasal syndrome and right hallux duplication

Placeholder

Organizational Units

Program

Authors

Authors

SEVEN, Mehmet
Gezdirici, Alper
Ulucan, Hakan
Karatas, Omer Faruk
Yosunkaya, Elif
Yuksel, Adnan
Ozen, Mustafa

Advisor

Language

Publisher

Journal Title

Journal ISSN

Volume Title

Abstract

Craniofrontonasal syndrome (CFNS, MIM #304110) is a rare X-linked dominant developmental disorder that shows paradoxically greater severity in affected females than in affected males. Our female patient with frontonasal dysplasia, craniosynostosis and additional malformations was consistent with CFNS. EFNB1, which encodes a member of the ephrin family of transmembrane ligands for Eph receptor tyrosine kinases, is the only gene in which mutation is known to cause CFNS. Here, we describe 402 T > C, a novel de novo mutation on EFNB1. This mutation results in substitution of highly conserved isoleucine at 134th residue to threonine. (C) 2013 Elsevier B.V. All rights reserved.

Description

Source:

Keywords:

Keywords

Citation

SEVEN M., Gezdirici A., Ulucan H., Karatas O. F. , Yosunkaya E., Yuksel A., Ozen M., -A novel EFNB1 mutation in a patient with craniofrontonasal syndrome and right hallux duplication-, GENE, cilt.527, ss.675-678, 2013

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads

View PlumX Details


Sustainable Development Goals